Quelles sont les heures d'ouverture ?

Lundi 08:00 - 16:00 Mardi 08:00 - 16:00 Mercredi 08:00 - 16:00 Jeudi 08:00 - 16:00 Vendredi 08:00 - 16:00

CRID Cameroon

Our vision is to save lives through quality research and capacity building in infectious and tropical diseases.
(1)

19/05/2026

CRID Executive Director attends Unitaid’s 20th anniversary

This week in , the 20th anniversary of brought together leaders in global , including Dr Philippe Duneton, Executive Director of Unitaid and Sir Jeremy Farrar, former Chief Scientist of and former Director of Wellcome Trust. Together with Prof Charles Wondji, discussions focused on building equitable partnerships to accelerate innovation against infectious diseases. CRID is proud to have earned Unitaid’s trust through our recent 5-year funding, which will help catalyze the adoption of novel vector control tools beyond bed nets.

Unitaid
Ministère de la Santé Publique du Cameroun
Programme National de Lutte contre le Paludisme - PNLP - Cameroun
Liverpool School of Tropical Medicine - LSTM

19/05/2026

📺🎙️High-Level Scientific achievement gains media recognition.
Congratulations once again, Dr. Gadji Mahamat !
Thank you, InfoTv Cameroun
Wellcome Trust
Université de Yaoundé I
Liverpool School of Tropical Medicine - LSTM
Programme National de Lutte contre le Paludisme - PNLP - Cameroun

18/05/2026

PROFESSOR GRANT HUGHES VISITS CRID
Friday, May 15, 2026 – Prof. Grant Hughes, Deputy Head of the Vector Biology Department at the Liverpool School of Tropical Diseases ( ), visited . The purpose of the visit was to explore potential areas of collaboration with CRID , particularly focusing on host–microbe interactions within mosquitoes and the molecular mechanisms underlying these interactions.
The visit began with discussions with CRID researchers working in this field, including Dr. Basile Kamgang, Head of the Disease Research Unit, and Dr. Marcel Sandeu, Co-Principal Investigator on the project at CRID.
This visit marks a renewed engagement since the conclusion of the Partnership to Increase the Impact of Vector Control ( ) project, which contributed to improving strategies to combat diseases such as , (sleeping sickness), arboviruses, and in .
According to Prof. Charles Wondji, Executive Director of CRID, the institution remains committed to building and sustaining mutually beneficial partnerships. The visit concluded with a tour of the facilities, including the room. Looking ahead, clear and actionable avenues for collaboration are expected to be established.
Liverpool School of Tropical Medicine - LSTM
Ministère de la Santé Publique du Cameroun
Gates Foundation
Programme National de Lutte contre le Paludisme - PNLP - Cameroun

17/05/2026

MAHAMAT GADJI DEFENDS HIS PHD THESIS ON WHOLE GENOME SEQUENCING IN ANOPHELES FUNESTUS
On Friday, 15 May 2026, at the Faculty of of the of Yaoundé I, Mahamat Gadji, Ph.D. student in the Department of , successfully defended his thesis entitled “Whole Sequencing for the Detection of Communities in funestus, a Major African Malaria Vector.” The jury, chaired by Prof. Etoa François Xavier ( ), received the work and congratulated him. The candidate was awarded the highest distinction and was encouraged to further explore other aspects and approaches. Notably, he is a pioneer in this field of in , advancing the study of microbial detection in Anopheles funestus. This research, carried out under the Trust project, was co-supervised by Prof. Wondji Charles (LSTM) and Prof. Boyomo Onana (UYI). Congratulations, Dr. Gadji Mahamat!

Université de Yaoundé I
Liverpool School of Tropical Medicine - LSTM
Wellcome Trust
Gadji Mahamat

@ à la une

13/05/2026

IMPACTING PROJECT POLICY ENGAGEMENT WORKSHOP HELD IN YAOUNDÉ
Yaoundé, May 13, 2026 — The IMPACTING Project, funded by the European Union under the , convened a high-level policy engagement workshop aimed at strengthening the prevention and control of Vector-Borne Diseases (VBDs) at both central and regional levels in Cameroon.
The workshop served as a platform to foster dialogue, strengthen multisectoral collaboration, and align policy actions to improve the prevention, surveillance, and control of VBDs in Cameroon. Participants discussed the epidemiological situation of vector-borne diseases in Cameroon, including disease burden, trends, surveillance systems, control strategies, and existing challenges. Key thematic areas included environmental, agricultural, and climate drivers of VBDs; the malaria situation and response; progress toward Human African Trypanosomiasis (HAT) elimination and surveillance; the status of Onchocerciasis elimination efforts; and arboviral disease risks and preparedness.
“The IMPACTING Policy Engagement Workshop seeks to advance innovative tools for vector monitoring and pathogen detection, engage communities and stakeholders in co-developing sustainable locally adapted solutions, and support evidence-based policymaking through a multi-disease risk prediction dashboard,” said Dr. Basile Kamgang, Principal Investigator of the IMPACTING Project in Cameroon.
Led by CRID, the workshop brought together key stakeholders including the Ministry of Public Health (MINSANTE), the Institut de Recherche pour le Développement (IRD), national disease control programmes — including the National Malaria Control Programme (NMCP), Onchocerciasis (NOCP), Human African Trypanosomiasis (HAT) control Programme — as well as representatives from the Ministry of Environmen (MINEPDED), Scientific Research and Innovation (MINRESI), Agriculture and Rural Development (MINADER), universities the Institute of Medical Research and Medicinal Plants Studies (IMPM), research institutions, international NGOs, media organizations, and technical partners.

Le Cirad en Afrique centrale
ICIPE - International Centre of Insect Physiology and Ecology
Icipe Alumni Portal
L'IRD en Afrique centrale
Centre Pasteur du Cameroun
Union européenne au Cameroun
Ministère de la Santé Publique du Cameroun
Ministère de la Recherche Scientifique et de l'Innovation

12/05/2026

HIGHEST DISTINCTION FOR BRICE NATCHEMA AT HIS PHD DEFENCE
On Monday 11 May 2026 at 10 a.m., the room S01–02 of the Department of Biology and Animal Physiology at the University of Yaoundé I was filled with an atmosphere that made it clear this would be no ordinary day. For Brice Natchema Fonkou, then a .D candidate, it marked the culmination of years of hard : his public defence. The hall was packed when the chair of the jury, Prof. Njiokou Flobert, gave him the floor.
Over forty minutes, Brice presented and defended his entitled “Influence of on the transmission of spp. in funestus Giles, 1900, a major vector in Cameroon.” His presentation was clear and well‑structured, richly illustrated with figures that highlighted the strength of his . He spoke with the confidence and authority of an emerging expert in his field. Facing him, a jury of international standing engaged in a high‑level, open debate. Their comments focused mainly on minor clarifications and formal adjustments, without calling into question the robustness or originality of the work.
At the end of the deliberations, the verdict left no room for doubt: the jury unanimously awarded Brice the Highest Distinction. This success is both a personal achievement and the reflection of excellent supervision provided by Prof. Lucia Nkengazong (IMPM) Prof. Tombi Lucia (University of Yaoundé I) and Prof. Charles Wondji (LSTM).

Nat Brice Fonkou
Gates Foundation
Ministère de la Santé Publique du Cameroun
Liverpool School of Tropical Medicine - LSTM
Université de Yaoundé I
@ à la Une
Follow Alana

12/05/2026

🚨 NEW PUBLICATION ALERT!
We’re pleased to share our latest study in eBioMedicine — “Modelling the impact of ivermectin-based optimal strategies on malaria control: the role of formulation, coverage, and mosquitocidal efficacy timing” by Franck Dongmo et al.
We developed a modeling framework that explicitly captures heterogeneous ivermectin clearance following drug administration, and its downstream effect on mosquitocidal efficacy. Long-acting injectable ivermectin outperforms oral regimens in sustained killing of resistant vectors, as evidenced by clinical and preclinical data: projected case reductions (95% CI) are reported across all regimens evaluated.
READ MORE 👉 https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(26)00160-X

Programme National de Lutte contre le Paludisme - PNLP - Cameroun
Ministère de la Santé Publique du Cameroun
Gates Foundation
Liverpool School of Tropical Medicine - LSTM

11/05/2026

FIELDWORK UPDATES
CRID is currently conducting field data collection activities in the Lagdo Health District as part of a study exploring stakeholders’ knowledge and perceptions of innovative vector control tools to accelerate malaria elimination, with a particular focus on Gene Drive technology.
The goal of the study is to understand what community members, local organizations, religious and traditional leaders, and health workers know and think about Gene Drive technology. It also aims to identify key people who can support future discussions and to understand what conditions may encourage or limit acceptance of this new approach in Cameroon. The fieldwork is led by Dr. Sougal Freitas and Dum-Buo Nnamdi, alongside research assistants Ami Bienvenu and Flore Ngounoue, under the coordination of the project Principal Investigator, Pr Wondji Charles.
Through this work, CRID continues to support community-based research that promotes ethical, inclusive, and locally appropriate strategies to fight malaria in Cameroon. This activity is funded by the Wellcome Trust through the Institut de Recherche en Sciences de la Santé (IRSS), Burkina Faso.

Charles Wondji
Wellcome Trust
Institut de Recherche en Sciences de la Santé - IRSS

08/05/2026

🚨 NEW PUBLICATION ALERT
We’re proud to see CRID expertise featured in Trends in Parasitology: “Adapting Africa’s vector surveillance systems to monitor gene-drive mosquitoes in malaria control” led by Fredros Okumu et al., with Prof Charles S. Wondji and Dr Magellan Tchouakui.
Gene‑drive mosquitoes could greatly improve malaria control. But because they spread quickly, countries need strong and practical monitoring after release : not new, costly systems built from scratch.
Our team shared a Central Africa perspective on how countries can do this using the systems they already have. This is a “no‑regret” investment: the same improvements needed to monitor gene‑drive mosquitoes will also strengthen everyday malaria mosquito tracking today.
Read more: 👉👉👉 https://www.cell.com/trends/parasitology/abstract/S1471-4922(26)00074-7

Liverpool School of Tropical Medicine - LSTM
Ministère de la Santé Publique du Cameroun
Gates Foundation
Programme National de Lutte contre le Paludisme - PNLP - Cameroun
Magers TK

06/05/2026

DR. LILI MBAKOP CONDUCTS FIELDWORK IN MOKOLO
From 28 April to 6 May 2026, Dr. Lili Mbakop, Post-doctoral researcher at CRID, led fieldwork activities in the Mokolo, Far North Cameroon. During one week, she investigated the ecological, entomological, and community determinants of Leishmaniasis in Mokolo.
During the fieldwork, Dr. Mbakop conducted in-depth interviews with health workers, community leaders, and local authorities, while Community Health Workers administered household questionnaires. At the same time, Centers for Disease Control and Prevention
(CDC) light traps were deployed to capture sandflies, providing essential information on the insects that transmit the disease. These combined activities are crucial for mapping community knowledge and practices while building a participatory surveillance system.
This hands-on experience not only deepened Dr. Mbakop’s understanding of local realities but also strengthened her expertise in participatory One Health surveillance.
This mission is part of a recently awarded grant from the Royal Society of Tropical Medicine and Hygiene ( ).

Liverpool School of Tropical Medicine - LSTM
Ministère de la Santé Publique du Cameroun
Royal Society of Tropical Medicine and Hygiene
Lili Ranaise Mbakop

05/05/2026

FORMATIVE SUPERVISION VISIT IN GAROUA-BOULAI HEALTH DISTRICT
As part of the ongoing Clinton Health Access Initiative (CHAI)-supported Malaria Rapid Diagnostic Test (RDT) Reader pilot in Cameroon, a CRID team conducted a formative supervision visit of three days in 16 health facilities across the Garoua Boulai health district (East Cameroon).
The visit focused on reinforcing correct implementation of standard operating procedures for malaria diagnosis, strengthening data recording practices at both facility and community levels, and ensuring the proper use of the RDT Reader technology. In addition, used RDT boxes were collected for manual cross checking and digital verification through the healthPulse App to assess data accuracy and system performance.
Through hands-on engagement and close collaboration with frontline health workers and district health staff, the team identified practical operational gaps and addressed them immediately through on-the-spot mentorship and coaching. Emphasis was placed on best practices in RDT handling, results interpretation, documentation, and reporting, ensuring health workers clearly understood expectations and felt supported in applying them.
These formative supervision visits play a critical role in improving data quality, strengthening system reliability, fostering user confidence and adoption of new diagnostic tools. By providing continuous feedback and capacity building, they help ensure that innovative solutions such as the RDT Reader are effectively integrated into routine practice and are scalable in low-resource settings.
CRID remains committed to supporting Cameroon’s efforts to improve malaria diagnosis and strengthen health systems through this study.

Liverpool School of Tropical Medicine - LSTM
Ministère de la Santé Publique du Cameroun
Dr Manaouda Malachie

Adresse

Nkoulou/carriere
Yaoundé
237

Heures d'ouverture

Lundi	08:00 - 16:00
Mardi	08:00 - 16:00
Mercredi	08:00 - 16:00
Jeudi	08:00 - 16:00
Vendredi	08:00 - 16:00

Téléphone

+237656605384

Site Web

http://crid-cam.net/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque CRID Cameroon publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.